DOI: http://dx.doi.org/10.18203/2320-6012.ijrms20220537

Cutaneous manifestations in COVID-19

Luh P. V. C. Sari

Abstract


Despite of primarily infecting the respiratory tract, coronavirus disease 2019 (COVID-19) may have an extensive extrapulmonary clinical manifestations, including the integumen system. Cutaneous manifestations of COVID-19 are polymorphic, hence it can be confused with any other identical lesions caused by other agents. This literature review concludes the cutaneous manifestations which can be found in COVID-19. COVID-19 may manifest as maculopapular rash, urticaria, vesicular lesions, covid toes, and livedo recamosa. Some of these cutaneous manifestations may have a significant prognostic value for diagnosing COVID-19. Although COVID-19 role in the integumen system is poorly understood, proper identification are needed to distinguish these lesions from different etiological agents.  

 


Keywords


COVID-19, Extrapulmonary, Cutaneous, Skin

Full Text:

PDF

References


Organization WH. Global surveillance for COVID-19 disease caused by human infection with the 2019 novel coronavirus, Interim guidance. 2020.

Marzano AV, Cassano N, Genovese G, Moltrasio C, Vena GA. Cutaneous manifestations in patients with COVID‐19: a preliminary review of an emerging issue. Br J Dermatol. 2020;183:431-42.

Galván Casas C, Catala A, Carretero Hernández G, Rodríguez‐Jiménez P, Fernández‐Nieto D, Rodríguez‐Villa Lario A et al. Classification of the cutaneous manifestations of COVID‐19: a rapid prospective nationwide consensus study in Spain with 375 cases. Br J Dermatol. 2020;183:71-77.

Organization WH. Weekly operational update on COVID-19. World Heal Organ Geneva, Switz. 2021;1-10.

Organization WH. Coronavirus disease (COVID-19): situation report. 2020;162.

Kementerian Kesehatan Republik Indonesia. Situasi COVID-19.2021.

Recalcati S. Cutaneous manifestations in COVID-19: a first perspective. J Eur Acad Dermatol Venereol. 2020;4:12-8.

Giavedoni P, Podlipnik S, Pericàs JM, Fuertes de Vega I, García-Herrera A, Alós L et al. Skin manifestations in COVID-19: prevalence and relationship with disease severity. J Clin Med. 2020;9:3261.

Mariyath OKR, Samad KA, Devi K, Surya VS, Effeena MD, Ajina M. Atypical maculopapular rash as the initial sign of COVID-19: A case report from a COVID hospital. J Ski Sex Transm Dis. 2021;3:87-90.

Sachdeva M, Gianotti R, Shah M, Bradanini L, Tosi D, Veraldi S, Ziv M et al. Cutaneous manifestations of COVID-19: Report of three cases and a review of literature. J Dermatol Sci. 2020;98:75-81.

Gottlieb M, Long B. Dermatologic manifestations and complications of COVID-19. Am J Emerg Med. 2020;38:1715-21.

Rahimi H, Tehranchinia Z. A comprehensive review of cutaneous manifestations associated with COVID-19. Biomed Res Int. 2020;2020.

Henry D, Ackerman M, Sancelme E, Finon A, Esteve E. Urticarial eruption in COVID‐19 infection. J Eur Acad Dermatology Venereol. 2020.

Hassan K. Urticaria and angioedema as a prodromal cutaneous manifestation of SARS-CoV-2 (COVID-19) infection. BMJ Case Reports CP. 2020;13:e236981.

De Giorgi V, Recalcati S, Jia Z, Chong W, Ding R, Deng Y et l. Cutaneous manifestations related to coronavirus disease 2019 (COVID-19): A prospective study from China and Italy. J Am Acad Dermatol. 2020;83:674-5.

Fernandez‐Nieto D, Ortega‐Quijano D, Jimenez‐Cauhe J, Burgos‐Blasco P, de Perosanz‐Lobo D, Suarez‐Valle A et al. Clinical and histological characterization of vesicular COVID‐19 rashes: a prospective study in a tertiary care hospital. Clin Exp Dermatol. 2020;45:872-875.

Wang CJ, Worswick S. Cutaneous manifestations of COVID-19. Dermatol Online J. 2021;27.

Baeck M, Herman A. COVID toes: where do we stand with the current evidence? Int J Infect Dis. 2021;102:53-5.

Colmenero I, Santonja C, Alonso‐Riaño M, Noguera‐Morel L, Hernández‐Martín A, Andina D et al. SARS‐CoV‐2 endothelial infection causes COVID‐19 chilblains: histopathological, immunohistochemical and ultrastructural study of seven paediatric cases. Br J Dermatol. 2020;183:729-37.

Cappel MA, Cappel JA, Wetter DA. Pernio (chilblains), SARS-CoV-2, and COVID toes unified through cutaneous and systemic mechanisms. In: Mayo Clinic Proceedings. Elsevier. 2021;96:989-1005.

Khalil S, Hinds BR, Manalo IF, Vargas IM, Mallela S, Jacobs R. Livedo reticularis as a presenting sign of severe acute respiratory syndrome coronavirus 2 infection. JAAD Case Reports. 2020;6:871-4.